Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide an update regarding upcoming data presentations at two international...

CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced it will participate in the 2023 Roth Healthcare...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chief Scientist of NRx...

Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, today announced the launch of ProSight™, its newest enterprise software platform. ProSight, which provides airports and...

In a significant leap towards bringing advanced emotional intelligence to AI, Source Code Technology (SCT) will unveil Symbolic Language at the prestigious GITEX Global 2023 in Dubai. Symbolic...

Mars Veterinary Health, Banfield Pet Hospital announce $25,000 grant to spur innovation that will help ensure care is available to pets VANCOUVER, Wash., Oct. 4, 2023 /PRNewswire/ -- Banfield Pet...

Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced a poster presentation highlighting...

Anju is pleased to announce its participation at the upcoming Society for Clinical Data Management (SCDM) conference, taking place from October 8-11, in San Diego, California. For 25 years SCDM...

Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced it will present preclinical data from its...

Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that preclinical data for agents targeting KRAS G12D, multiple oncogenic KRAS mutations and Nectin-4, will be...